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Polarized trafficking of synaptic proteins to axons
and dendrites is crucial to neuronal function.
Through forward genetic analysis in C. elegans, we
identified a cyclin (CYY-1) and a cyclin-dependent
Pctaire kinase (PCT-1) necessary for targeting
presynaptic components to the axon. Another cy-
clin-dependent kinase, CDK-5, and its activator
p35, act in parallel to and partially redundantly with
the CYY-1/PCT-1 pathway. Synaptic vesicles and
active zone proteins mostly mislocalize to dendrites
in animals defective for both PCT-1 and CDK-5 path-
ways. Unlike the kinesin-3 motor, unc-104/Kif1a
mutant, cyy-1 cdk-5 double mutants have no reduc-
tion in anterogradelymoving synaptic vesicle precur-
sors (SVPs) as observed by dynamic imaging.
Instead, the number of retrogradely moving SVPs is
dramatically increased. Furthermore, this mislocali-
zation defect is suppressed by disrupting the retro-
grade motor, the cytoplasmic dynein complex.
Thus, PCT-1 and CDK-5 pathways direct polarized
trafficking of presynaptic components by inhibiting
dynein-mediated retrograde transport and setting
the balance between anterograde and retrograde
motors.INTRODUCTION
Neurons are highly specialized cells capable of transmitting and
processing information through their polarized cellular
processes: dendrites receive signals through neurotransmitter
receptors and transform these signals into electrical impulses,
while axons convert these electrical impulses into chemical
signals at presynaptic sites through synaptic vesicle cycles.846 Cell 141, 846–858, May 28, 2010 ª2010 Elsevier Inc.Therefore, the localization of synaptic vesicles and other active
zone components at axonal presynaptic sites is absolutely
essential for neuronal function.
How are these axonal or dendritic molecules localized appro-
priately? There are multiple possible routes that diverge at the
levels of sorting, trafficking, and retention (Horton and Ehlers,
2003). Proteins are sorted into different carrier vesicles in the
cell body. Certain vesicles are specifically transported to one
compartment, while others travel into multiple compartments
before being selectively retained in one compartment.
The sheer length of most axons and their lack of protein
synthesis machinery demands efficient transport systems to
traffic synaptic vesicle precursors (SVPs) and active zone
components from the cell body to the axons. Intriguingly, studies
in dissociated neuronal cultures showed that several axonal
proteins such as synaptic vesicle v-SNARE VAMP2/synaptobre-
vin, cell adhesion molecule L1/neuron-glia cell adhesion mole-
cule NgCAM, and sodium channel Nav1.2, are initially trans-
ported to both the axon and dendrites but later localize to the
axon through transcytosis (Burack et al., 2000; Garrido et al.,
2001; Sampo et al., 2003; Wisco et al., 2003; Yap et al., 2008).
These results indicate that there are trafficking mechanisms
both to bring axonal cargo to the dendrite and to transport
them into axons.
Themicrotubule cytoskeletonand relatedmolecularmotors are
largely responsible for the long-range traffickingof axonal compo-
nents.Microtubules are oriented plus-end distal in the axon,while
they have mixed polarity in dendrites (Baas et al., 1988). The vast
majority of themembersof the kinesin superfamilymoveunidirec-
tionally toward the plus end of microtubules, while cytoplasmic
dyneins transport cargo in the opposite direction (Hirokawa
and Takemura, 2005; Vale, 2003). These molecular motors are
highly regulated. They recognize various cargo through direct
binding or by utilizing different adaptors. Different adaptors are
sufficient toguidemotors towardaxonsordendrites.Overexpres-
sion of the KIF-5-interacting domain of glutamate receptor-inter-
acting protein 1 (GRIP) causes KIF-5 to accumulate in dendrites
while overexpression of JIP3/Sunday driver leads to KIF-5
accumulation in axons (Setou et al., 2000). Other regulators can
associate with motors and modulate their activity. For example,
the retrograde motor dynein and its regulator LIS1 associate
with Nudel, a factor phosphorylated by cyclin-dependent
kinase-5 (CDK-5) (Niethammer et al., 2000; Sasaki et al., 2000). In-
hibitingCDK-5 phosphorylation of NUDEL in vitro disrupts neurite
morphology, a defect observed in dynein mutants as well. The
tight regulation of motors is not surprising given the wide array
of cargo that they transport to diverse locations.
In vivo studies identified two kinesin family motors and the
dynein complex to be important for trafficking presynaptic
components. UNC-104/Imac/KIF1A, a member of the kinesin-3
family, is the primary motor responsible for transporting SVPs.
Mutant worms and flies lacking this gene product show almost
complete failure of axonal trafficking—most SVPs accumulate
in neuronal cell bodies (Hall and Hedgecock, 1991; Pack-Chung
et al., 2007). The conventional kinesin-1/KIF5/KHC also plays
a role in this process as it bindsSVPs, anddisruption of thismotor
or its adaptor reduces the levels of SVPs and the active zone
protein bassoon at presynaptic sites (Cai et al., 2007;
Sato-Yoshitake et al., 1992). Third, disrupting components of
the cytoplasmic dynein complex leads to misaccumulation of
synaptic proteins (Fejtova et al., 2009; Koushika et al., 2004).
Taken together, these results indicate that the localization of
presynaptic components requires the cooperation of multiple
motors. However, how motors are regulated to distinguish
between axons and dendrites, how presynaptic cargo is depos-
ited specifically at presynaptic sites, and how different motors
interact with one another are important questions that remain to
be addressed.
Here, we utilized an in vivo system in C. elegans to study the
intracellular trafficking of SVPs and active zone proteins. We
identified two cyclin-dependent kinase pathways that are essen-
tial for axonal localization of presynaptic components. Our
results suggest that these kinase pathways regulate the localiza-
tion of presynaptic components by inhibiting retrograde traf-
ficking that is likely mediated through the dynein motor.
RESULTS
Presynaptic Components Mislocalize to the Dendrite
of the DA9 Motor Neuron in wy575 and wy302 Mutants
The cholinergic motor neuron DA9 elaborates a morphologically
and molecularly distinct axon and dendrite, and is well suited
for the study of mechanisms regulating the polarized localiza-
tion of axonal and dendritic proteins in vivo. We visualized
both presynaptic components and dendritic proteins in DA9
using cell-specific promoters (itr-1 pB or mig-13) to express flu-
orescently tagged protein markers in vivo. Consistent with elec-
tron microscopic reconstruction data (White et al., 1976),
synaptic vesicle proteins and active zone markers localize
only to a discrete segment of the axon while several proteins
localize selectively to the dendrite (Klassen and Shen, 2007;
Poon et al., 2008).
To identify factors important for localizing presynaptic compo-
nents, we visually screened randomly mutagenized animals for
mutants with abnormal distribution patterns of presynaptic
components. We isolated two mutants with similar and fullypenetrant defects with presynaptic markers present in both
axons and dendrites. In both wy575 and wy302 mutants,
synaptic vesicle-associated RAB-3, active zone component
SYD-2/liprin-a, synaptic vesicle transmembrane proteins SNB-
1/synaptobrevin and SNG-1/synaptogyrin mislocalize to the
DA9 dendrite (Figure 1B, Figure 1C, Figure 1H, and Figure 1I
compared with Figure 1A and Figure 1G, and Figures S1A–S1L
available online). DA9 axonal and dendritic morphology is other-
wise normal. Furthermore, the majority of the presynaptic
proteins is still distributed in the axon, and these proteins coloc-
alize with one another in the normal synaptic domain (Figures 1H
and 1I). These results indicate that except for mislocalized
presynaptic components, many aspects of DA9 development,
including axon guidance, dendrite outgrowth, and synaptic
target selection, are normal in these two mutants. Consistent
with this notion, while both wy575 and wy302 mutants have
slightly lower brood sizes, they are fertile, active, and exhibit
largely normal locomotion.
wy575 and wy302 Are Mutant Alleles
of aCyclin-Dependent Kinase and aCyclin, Respectively
Using single nucleotide polymorphism mapping, transgenic
rescue, and sequence analysis, we mapped the wy575 muta-
tion to pct-1, which encodes a highly conserved Pctaire kinase
of the cyclin-dependent kinase family (Figures S1U and S1V).
Pctaire kinases have been implicated in neurite outgrowth,
exocytosis, and tau phosphorylation (Graeser et al., 2002;
Herskovits and Davies, 2006; Liu et al., 2006). cDNA sequences
predict three isoforms of PCT-1 with common C-terminal kinase
domains and variable N-terminal sequences. wy575 is
a missense mutation of a highly conserved aspartic acid residue
in the ATP-binding pocket of the kinase (D377N). We also
examined the phenotypes of two different deletion alleles of
pct-1 in DA9: one affects two of the three isoforms (ok1707)
while the other removes the kinase domain in all three isoforms
and is a predicted null (tm2175). ok1707 mutants have no mis-
localization defect, while tm2175 mutants are indistinguishable
from wy575 mutants (Figure 2J), suggesting that the third iso-
form is sufficient and that both wy575 and tm2175 are likely
null alleles.
Using similar methods, wemappedwy302 at the genetic locus
ZK353.1. This gene encodes two highly similar isoforms contain-
ing a predicted cyclin domain. It is orthologous to mammalian
cyclin Y that has not been studied previously (Figures S1X and
S1Y). We named the gene CYY-1 (Cyclin Y). The wy302 allele
results in a stop codon in the ninth amino acid and likely repre-
sents a null allele.
PCT-1, CYY-1, CDK-5, and CDKA-1/p35 Act Cell
Autonomously in DA9 to Ensure the Polarized
Localization of Presynaptic Components
Since the phylogenetic analysis shows that PCT-1 is most
closely related to CDK-5 (Figure S1U), we further exam CDK-
5 and other CDK mutants. While mutations in CDK-1, CDK-
7, and CDK-8 have no effect (data not shown), null mutations
in cdk-5 or its activator cdka-1/p35 lead to dendritic
accumulation of presynaptic components (Figures 2A and
2B, Figure S1). Like the pct-1 and cyy-1 mutants, thisCell 141, 846–858, May 28, 2010 ª2010 Elsevier Inc. 847
Figure 1. Synaptic Vesicle-Associated RAB-3 and Active Zone Protein SYD-2/Liprin-a Mislocalize to the DA9 Dendrite in wy575 or wy302
Mutants
(A) A wild-type adult expressing GFP::RAB-3 in DA9(wyIs85).
(B and C) Two mutants expressing GFP::RAB-3.
(D–F) Schematic diagrams of GFP::RAB-3 distribution.
(G–I) Wild-type (G) and mutant animals (H and I) coexpressing GFP::SYD-2/liprin-a and mcherry::RAB-3(wyEx2055). (G’-I’, G’’-I’’) Higher magnification micro-
graphs of the corresponding dotted boxes. The fluorescence in the middle of the worm is gut autofluorescence. Anterior, left; and dorsal, top. Bracket, dendrite;
asterisk, above cell body.
The scale bar represents 10 mm. See also Figure S1.mislocalization defect in cdk-5 or cdka-1/p35 mutants is fully
penetrant. The mutant animals have normal DA9 guidance
and morphology, and do not exhibit obvious defects in loco-
motory behavior.
We subsequently determined if these four genes are
expressed endogenously in DA9. Cytoplasmic fluorophore
under the control of their endogenous promoters, revealed
fluorescence in DA9 as well as other ventral cord motor
neurons (data not shown). CYY-1 is also expressed in other
tissues such as the gut and gonad. Using the itr-1 pB promoter
that drives expression specifically in DA9 in the tail, we asked if
DA9-specific expression of each gene is sufficient to rescue
the mislocalization defect of SVPs. For each gene, we gener-
ated two independent transgenic strains expressing the corre-
sponding cDNA or genomic fragment in DA9. Expression of
these four genes in DA9 almost completely rescues the mutant
phenotype, suggesting that PCT-1, CYY-1, CDK-5, and CDKA-
1/p35 act cell-autonomously in DA9 (Figure 2C).
PCT-1, CYY-1, CDK-5, and CDKA-1/p35 Act in Parallel
Pathways
Since pct-1, cyy-1, cdk-5, and cdka-1/p35 mutants have similar
defects, we investigated their genetic relationships. Using puta-848 Cell 141, 846–858, May 28, 2010 ª2010 Elsevier Inc.tive null mutants, we generated all six combinations of double
mutants and compared them with the single mutants (Figures
2D–2I). Quantitative analysis of GFP::RAB-3 distribution in the
DA9 axon and dendrite showed that between 19%–47% of total
RAB-3 fluorescence is present in the dendrite of these single
mutants compared to 0.3% in wild-type animals (Figure 2J). As
cyy-1; pct-1 double mutant animals are indistinguishable from
each single mutants, PCT-1 and CYY-1 likely function in the
same genetic pathway. Likewise, cdka-1/p35 cdk-5 double
mutant animals have a mislocalization defect similar to cdk-5
single mutants, a result one would expect if CDKA-1/p35 acti-
vates CDK-5.
The other four double mutants, on the other hand, exhibit
dramatically enhanced mislocalization defects. Nearly all SVPs
(86%–98%) are present in the DA9 dendrite in the cdk-5; pct-
1, cdka-1/p35; pct-1, cyy-1 cdk-5, and cdka-1/p35 cyy-1 double
mutants (Figures 2F–2J). The active zone protein SYD-2/liprin-
a is similarly dramatically mislocalized in these double mutants,
suggesting that trafficking and localization of multiple presyn-
aptic components are defective (Figure S2). To address if these
defects are specific to the cholinergic DA9 neuron, we examined
the localization of synaptic vesicle-associated RAB-3 in other
neurons. We found that the GABAergic DD motor neurons and
Figure 2. PCT-1, CYY-1, CDK-5, and CDKA-1/p35
Act in Two Pathways in DA9
(A and B) cdk-5(ok626) (A) or cdka-1/p35(tm648) (B)
mutant animal expressing GFP::RAB-3(wyIs85). Bracket,
dendrite; asterisk, above cell body.
(C) DA9-specific expression of the four genes rescues the
GFP::RAB-3(wyIs85) mislocalization defect (wyEx2286-
9,2860-1). n = 100. ***p < 0.0001. c2 test.
(D–I) Double mutants expressing GFP::RAB-3. Bracket,
dendrite; asterisk, above cell body. The scale bar repre-
sents 10 mm.
(J) Graph of severity of GFP::RAB-3 mislocalization. Error
bars represent the standard error of the mean (SEM). n =
20. ***p < 0.0001 compared withwild-type. n.s., not signif-
icant. t test.
See also Figure S2.the RIA interneurons are also severely affected in cyy-1 cdk-5
double mutants and GFP::RAB-3 mislocalizes to dendrites or
dendritic segments (Figure S3). Intriguingly, the localization of
synaptic vesicle markers in the cholinergic DB motor neuronsCell 141is only mildly affected in cyy-1 cdk-5 double
mutants (data not shown), suggesting that these
two pathways are required for many but not all
neurons. Not surprisingly, these four double
mutants are largely paralyzed, indicating a loss
of functional synapses in motor neurons. These
results are consistent with pct-1 and cyy-1
acting in a pathway parallel to cdk-5 and cdka-
1/p35 in multiple neurons. The observed drastic
enhancement further highlights that these two
pathways are essential for the polarized locali-
zation of presynaptic components.
To definitively understand the synaptic
structural defects in the cyy-1 cdk-5 double
mutants, we reconstructed segments (4–7mm)
of the dorsal nerve cord using serial electron
microscopy (EM) from three cyy-1 cdk-5
double mutant animals and three wild-type
control animals. Consistent with our findings
with fluorophore-tagged synaptic markers, we
found that the number of synaptic vesicles
and active zones in the DA and DD axons are
significantly reduced whereas presynaptic
specializations in the DB neurons appear
normal (Figure 3 and unpublished data, S.W.
and K.S.). Since the reconstruction was per-
formed where the DA1 to DA4 neurons form
synapses, the synaptic vesicle localization
defect in DA neurons is not limited to DA9,
but is true for the anterior DA neurons as
well. This EM analysis also revealed that the
size and appearance of the synaptic vesicles
in cyy cdk-5 mutants is indistinguishable from
that in wild-type controls. Furthermore, the
appearance of the muscle arms and their
contacts with the motor neurons are largelynormal, arguing that the wiring of the motor circuits remains
intact in the mutant animals (data not shown).
The close phylogenetic relationship, the similarity of their loss-
of-function phenotypes, and the enhanced phenotype of the, 846–858, May 28, 2010 ª2010 Elsevier Inc. 849
Figure 3. The Number of Synaptic Vesicles
and Active Zones is Reduced in the Dorsal
Axons of DA Neurons in cyy-1 cdk-5 Double
Mutants
(A–F) Representative EM images of varicosities of
DA (A and B) and DB (C and D) neurons in wild-
type (A and C) or cyy-1 cdk-5 mutant animals (B
and D). Arrows, active zones. (E) Graph of average
density of synaptic vesicles in each varicosity in
DA and DB neurons. Error bars represent SEM.
Number of varicosities = 4 - 8. ***p < 0.0005. t
test. (F) Graph of varicosities with active zones in
DA and DB neurons. Number of varicosities = 4 –
8. ***p < 0.0001. c2 test. See also Figure S3.double mutants indicate that the PCT-1 and CDK-5 pathways
might perform similar and redundant functions in DA9.
To directly address this, we examined if over-activating one
pathway could compensate for the loss of the other pathway.
Indeed, we found that overexpression of PCT-1 in cdk-5mutants
significantly rescues their mislocalization defects, and likewise,
overexpression of CDK-5 significantly rescues defects of pct-1
mutant animals (Figure 4A).
CYY-1 Acts as an Essential Activator of PCT-1
While it is well established that p35 directly binds to and acti-
vates CDK-5 (Lew et al., 1994; Tsai et al., 1994; Uchida
et al., 1994), the interaction between CYY-1 and PCT-1 has
not been studied. No vertebrate cyclin is known to activate
Pctaire kinases (Liu et al., 2006). We therefore tested if
CYY-1 associates with and activates PCT-1 using tagged re-
combinant CYY-1 and PCT-1 in 293T cells. We observed that
CYY-1 and PCT-1 robustly coimmunoprecipitate with each
other regardless of the tag we used to perform the pull-down
experiment (Figure 4B). Furthermore, the kinase activity of
PCT-1 is strictly dependent on the presence of CYY-1
(Figure 4C). Consistently, overexpression of functional PCT-1
completely fails to rescue the cyy-1 mutants, indicating that
the function of PCT-1 depends on CYY-1 (Figure 4D). These
results strongly suggest that CYY-1 directly binds and activates
PCT-1 to regulate the localization of presynaptic components.850 Cell 141, 846–858, May 28, 2010 ª2010 Elsevier Inc.If PCT-1 is the only downstream
factor of CYY-1, CYY-1 should have no
activity in pct-1 null mutant animals.
However, we observed that overexpres-
sion of CYY-1 significantly rescues the
mislocalization defect in pct-1(tm2175)
mutant animals (Figure 4D). This indi-
cates that overexpression of CYY-1
can affect the localization of presynaptic
components through a mechanism
independent of PCT-1. A primary candi-
date is CDK-5 since it is closely related
to PCT-1 and we observed that the
CDK-5 transgene that robustly rescues
pct-1 mutant animals only marginally
rescues cyy-1 mutant animals (Fig-ure 4A). As presented in Figure 4D, the CYY-1 transgene that
rescues the mislocalization defect in pct-1 mutants completely
fails to rescue the mislocalization defect in cdk-5; pct-1 or
cdka-1/p35; pct-1 double mutants. Taken together, these
genetic interaction studies indicate that CYY-1 acts upstream
of PCT-1 and can also potentially activate the CDKA-1/p35-
CDK-5 pathway.
To further test whether CYY-1 can directly activate CDK-5,
we performed in vitro kinase assays. We found that the kinase
activity of CDK-5 can indeed be stimulated by CYY-1 suggest-
ing that CYY-1 might also be an activator of CDK-5
(Figure S4A).
Subcellular Localization of PCT-1, CYY-1, CDK-5,
and CDKA-1/p35
Next, we examined the subcellular localization of PCT-1,
CYY-1, CDK-5, and CDKA-1/p35. We found that CDK-5::YFP
predominantly localizes to presynaptic sites and is present as
faint puncta in the dendrite (Figure S4C). CDKA-1/p35::YFP
shows a presynaptic distribution in the axon and a punctate
localization pattern in the dendrite (Figure S4E). The localization
of CDK-5 is completely dependent on UNC-104/KIF1A (data
not shown). Consistent with the presynaptic localization of
the vertebrate CDK-5 (Tomizawa et al., 2002), these two distri-
bution patterns suggest that CDK-5 and CDKA-1/p35 are likely
to be associated with presynaptic components.
Figure 4. CYY-1 Activates PCT-1 and
Possibly CDK-5
(A) PCT-1 or CDK-5 suppresses the GFP::RAB-3
mislocalization defects in cdk-5 and cdka-1/p35
mutants or pct-1 and cyy-1 mutants respectively
(wyEx2506-7,2624,2626). n = 100. ***p < 0.0001.
c2 test.
(B and C) PCT-1-HA and/or CYY-1-FLAG were
coexpressed in 293T cells as indicated. (B)
Lysates were coimmunoprecipitated with HA and
FLAG antibodies, and then immunoblotted with
FLAG and HA antibodies respectively. (C) PCT-1
was coimmunoprecipitated with HA antibody and
kinase activity was measured in vitro using myelin
basic protein (MBP) as substrate.
(D) pct-1 weakly suppresses the cyy-1 defect,
while cyy-1 partially suppresses the pct-1 defect
in a CDK-5 or CDKA-1/p35-dependent manner
(wyEx2506-7,2776-7). n = 100. ***p < 0.0001. **p
< 0.001. n.s., not significant. c2 test.
See also Figure S4.Interestingly, CDK-5 andPCT-1 have very different localization
patterns. PCT-1::GFP is diffusely localized within DA9 and labels
both the dendrite and axon evenly (Figure S4B). CYY-1::YFP is
also present in both axons and dendrites, but is enriched in the
dendrite and proximal axon (Figure S4D). Taken together, if
CYY-1 is required for the activity of PCT-1, one would imagine
that the activity of PCT-1 is highest in the dendrite and lowest
in the synaptic domain and distal axon.
Collectively, these data suggest that although both PCT-1 and
CDK-5 affect similar biological processes, their exact cell biolog-Cell 141, 846–ical functions in vivo might be different.
However, they can substitute for each
other when overexpressed in the single
mutant background.
Dendritic Mislocalization of
Presynaptic Components in CDK
Mutants Is Unlikely to Be Caused by
Axon-Dendrite Specification or
Synapse Assembly Defects
After establishing the genetic and
biochemical interactions between PCT-
1, CYY-1, CDK-5, and CDKA-1/p35, we
considered the following three possibili-
ties thatmay lead to dendritic presynaptic
components: (1), a defect in axon-
dendrite specification; (2), a failure of
local assembly at presynaptic specializa-
tions; and (3), an impairment of intracel-
lular transport of presynaptic compo-
nents.
To address the first possibility, we
examined DA9 axonal and dendritic guid-
ance and outgrowth, trafficking of plus-
andminus-end directedmotors, dendriticproteins, and a non-synaptic axonal cargo. Both the timing and
directionality of axonal and dendritic outgrowth are normal in
cyy-1 cdk-5 double mutants (Figures S5A–S5D, data not shown).
The overall MT organization in both the axon and dendrite is
generally unaltered in the absence of the CDKpathways assayed
by the subcellular distribution ofMT-basedmotors (Figures S5E–
S5H). Futhermore, we examined four dendritic proteins including
CAM-1/ROR receptor tyrosine kinase, UNC-9/innexin, DYS-1/
dystrophin, and fibrillin (Poon et al., 2008; Sieburth et al., 2005)
and they localize nomally to dendrites in cyy-1 cdk-5 mutant858, May 28, 2010 ª2010 Elsevier Inc. 851
Figure 5. TheCDKsAffect Axonal Transport
of Presynaptic Components
(A and B) Wild-type (A) or unc-104/kif1a mutant
animal (B) expressing GFP::RAB-3(wyIs85). RAB-
3 is only present in the cell body and dendrite in
the unc-104/kif1a mutant animal.
(C and D) cyy-1 cdk-5 mutant animal expressing
GFP::RAB-3 in the absence (C) or presence (D)
of an unc-104/kif1a transgene expressed in
DA9(wyEx2694).
(E) UNC-104/KIF1A partially suppresses the
GFP::RAB-3 mislocalization defect in cyy-1 cdk-
5 mutant animals. n > 100. ***p < 0.0001. c2 test.
(F) GFP::RAB-3 in unc-104/kif1a; cyy-1 cdk-5
mutant animal. Bracket, dendrite; asterisk, above
cell body.
The scale bar represents 10 mm. See also
Figure S5.animals (Figures S5I–S5P). Glutamate receptor localizes to
dendrite of another neuron RIA, further indicating that trafficking
of dendritic cargo is unaffected (Figure S3H and Figure S3K).
Lastly, we investigated if other axonal cargo are trafficked nor-
mally. TOM20, a subunit of the mitochondrial translocase
complex, remains present in the axon in cyy-1 cdk-5 mutant
animals (Figures S5Q andS5R), suggesting that non-presynaptic
axonal cargo continues to be trafficked appropriately to the
axon. Taken together, our data suggest that general axon and
dendrite specification is normal in the absence of the CDK path-
ways and that the CDKs specifically affect localization of presyn-
aptic components and not other axonal or dendritic cargo.
Is the failure of local assembly at presynaptic specializations
the direct cause for dendritic mislocalization of presynaptic
components in cdk-5 or pct-1 mutant? Since cdk-5 or pct-1
single mutants have a relatively normal accumulation of RAB-3
in the presynaptic region compared with the syd-1; syd-2/
liprin-a double mutants that have severe presynaptic assembly
defects in DA9 whereas cdk-5 or pct-1 single mutants exhibit
muchmore severe accumulation of RAB-3 in the dendrites, there
is no correlation between defective presynaptic assembly and
the accumulation of stable RAB-3 puncta in the dendrite (Figures
S5S and S5T). It is thus unlikely that the assembly defect alone
can fully account for the dramatic mislocalization of presynaptic
components in cyy-1 cdk-5 double mutants.
We then considered the third possibility that the CDK path-
ways regulate intracellular transport of presynaptic compo-
nents. Since intracellular transport occurs continuously
throughout the life of the neuron, we expect the CDKs to be
required continuously if they regulate transport. Using a temper-
ature-dependent silencing strategy (Poon et al., 2008), we
observed that disruption of PCT-1 or CDK-5 late in develop-
ment is sufficient to mislocalize SVPs to the dendrite. In addi-852 Cell 141, 846–858, May 28, 2010 ª2010 Elsevier Inc.tion, rescuing PCT-1 or CDK-5 late in
development is sufficient to partially re-
move ectopic SVPs from the dendrite
(Figures S6A–S6C). These findings sug-
gest that both CDKs are required tomaintain the polarized localization of SVPs and that this defect
is reversible.
PCT-1 and CDK-5 Genetically Interact with the Kinesin
Motor UNC-104/KIF1A
To further understand how the CDK pathways regulate molec-
ular transport, we examined the primary motor responsible for
SVP transport, UNC-104/KIF1A, in greater depth. Consistent
with previous reports (Hall and Hedgecock, 1991), we found
that RAB-3 is completely absent from the axon of unc-104
mutants, suggesting that UNC-104 is the key anterograde motor
responsible for the axonal transport of SVPs. Surprisingly, we
also found that SVPs dramatically accumulate in the DA9 cell
body and dendrite of unc-104 mutants, a phenotype similar to
that observed in cyy-1 cdk-5 double mutants (Figure 5B). This
distribution pattern indicates that there might be another motor
that transports SVPs into the dendrite in the absence of the
UNC-104 motor. The similar phenotypes caused by disrupting
both CDK pathways or by mutations in UNC-104 suggest that
they might be involved in the same biological process. Consis-
tent with this notion, the unc-104; cyy-1 cdk-5 triple mutants
are indistinguishable from the unc-104 single mutant (Figure 5F).
To further understand the relationship between UNC-104 and
the CDK pathways, we overexpressed UNC-104 in the absence
of both CDK pathways. As seen in Figures 5D and 5E, UNC-104
expression leads to a partial suppression of the dendritic RAB-3
phenotype. In about 30% of the animals, the dendritic RAB-3
signal is completely absent, suggesting that overproduction of
UNC-104 can partially compensate for the loss of both CDK
pathways by trafficking SVPs to the axon (Figure 5E). However,
despite the absence of dendritic RAB-3 in these animals, their
dorsal axonal RAB-3 distribution is still significantly different
from that in wild-type animals (Figure 5D). There are fewer and
Figure 6. The CDKs Inhibit Retrograde Transport of Presynaptic Components
(A) Left: Schematic diagram of the DA9 neuron and the localization of RAB-3. Right: Representative image of GFP::RAB-3(wyEx2793) signal in the dorsal
asynaptic domain, where movies were taken.
(B) Image sequence visualizing moving GFP::RAB-3 puncta (blue arrowhead points to a retrogradely moving puncta while red arrowhead corresponds to
anterogradely moving puncta). The scale bar represents 5 mm.
(C) Kymograph of the movie shown in (B).
(D) Quantification of vesicle speeds in anterograde and retrograde direction in wild-type, unc-104(e1265wy565), cyy-1 cdk-5, and dhc-1(js319); cyy-1 cdk-5
mutant animals. All three mutants show a decrease in anterograde velocity. Error bars represent SEM. ***p < 0.0001. t test.
(E) Absolute numbers of vesicles moving in an anterograde or retrograde direction. Numbers above the bars represent percentages in relation towild-type. While
unc-104(e1265wy565)mutants show a dramatic decrease in the number of anterogradely- and retrogradely-moving vesicles, cyy-1 cdk-5mutant animals show
a significant increase in retrograde transport. ***p < 0.0005; **p < 0.005; *p < 0.05, Wilcoxon rank sum test.
See also Figure S6.dimmer RAB-3 puncta, which are spread over a larger than
normal segment of the dorsal axon. Though these results
suggest that the CDKs are likely also involved in events distinct
from UNC-104-mediated anterograde transport, they are
consistent with the CDK pathways affecting intracellular trans-
port of presynaptic components.
PCT-1 and CDK-5 Inhibit Retrograde Transport of SVPs
To further elucidate how the CDK pathways affect intracellular
transport, we performed time-lapse imaging experiments to
visualize transporting SVPs in DA9 in vivo. We found that there
are numerous small RAB-3 puncta in the axonal segment
between the cell body and the dorsal synaptic domain
(Figure 6A). These dim puncta are often motile during imaging
sessions that last up to a minute, unlike synaptic RAB-3 puncta
that remain stable over several days (data not shown). These
motile RAB-3 puncta are missing from the axon in unc-104
mutants, suggesting that trafficking utilizes the same molecular
motor as the synaptic vesicles. Hence, we hypothesize that
these small puncta represent motile SVPs during axonal trans-
port.
Time-lapse imaging experiments were performed on the
dorsal asynaptic segment of the axon immediately proximal to
the synaptic region of DA9 (Figures 6A–6C). Measurements inwild-type animals revealed that 76% of the movements are
toward the distal axon (anterograde), while 24% of the moving
events are retrograde. The average speed of anterograde events
is 1.9 mm/s, similar to the speed of dense core vesiclesmeasured
in vivo inC. elegans (Zahn et al., 2004). The average speed of the
retrograde movements is 2.3 mm/s, similar to the speed of the
retrograde motor dynein in living Dictyostelium cells (Ma and
Chisholm, 2002). In order to understand if UNC-104 mediates
anterograde movements, we measured the speed of antero-
grade events in a hypomorphic allele unc-104(e1265wy565).
We found that only the speed of anterograde movements, but
not retrograde events, is drastically reduced, suggesting that
UNC-104 mediates anterograde movements (Figure 6D).
Besides the speed, we also measured the absolute number of
anterograde and retrograde movement events. In unc-
104(e1265wy565) mutants, the absolute number of anterograde
events is drastically reduced, consistent with a weakened anter-
ograde motor. Retrograde movement is also reduced, but to
a lesser extent, probably due to the reduction of available
SVPs to be measured in the mutant axon. Unlike unc-
104(e1265wy565) mutants, the number of anterograde events
is not significantly altered in cyy-1 cdk-5 double mutants.
Instead, we observed a dramatic increase in retrograde events
(194% compared with wild-type, Figure 6E). Other dynamicCell 141, 846–858, May 28, 2010 ª2010 Elsevier Inc. 853
parameters such as the run length and the pause rate remain
unaffected in the cyy-1 cdk-5 double mutant (data not shown).
Though unc-104(e1265wy565) mutants exhibit a severe impair-
ment in anterograde SVP transport judging from the speed and
number of anterograde events (Figures 6D and 6E), there is still
significantly more RAB-3 signal in the unc-104(e1265wy565)
mutant axon compared with the cyy-1 cdk-5 double mutant
(Figure S6D-E). Based on these data, it is more likely that the
dramatic increase in retrograde events in cyy-1 cdk-5 double
mutants leads to an imbalance between anterograde and retro-
grade trafficking, ultimately resulting in failed assembly of
presynaptic specializations in the axon and ectopic accumula-
tion of presynaptic components in the dendrite. Similar dynamic
measurements in cdk-5 or cyy-1 single mutants also reveal
imbalanced trafficking with an abnormally high ratio of retro-
grade events. The amplitude of the defect in single mutants is
smaller compared with that of the double mutants (Figure S6F).
Hence, we hypothesize that the CDK pathways promote axonal
transport by inhibiting retrograde transport. The most direct
prediction of this hypothesis is that mutations in a retrograde
motor should suppress the mislocalization defect in the CDK
mutants.
PCT-1 and CDK-5 Likely Regulate SVP Transport
by Inhibiting the Cytoplasmic Dynein Complex
To further identify other downstream components of the CDK
pathways, we conducted an unbiased cdk-5 suppressor screen
and isolated five mutants with little or no dendritic RAB-3 in the
cdk-5 mutant background. Four belong to a single complemen-
tation group and we mapped one of the four, wy622, which
turned out to be a mutant allele of DHC-1, which encodes
C. elegans ortholog of the heavy chain of the retrograde motor
dynein (Figure 7A). Sequence analysis revealed that wy622
represents a point mutation in a conserved leucine residue in
N-terminal region 2, while the previously characterized but
unsequenced loss-of-function allele js319 represents a splice
acceptor mutation at the end of intron 12 in the C-terminal
conserved region (Figure 7A) (Koushika et al., 2004). We gener-
ated dhc-1; cdk-5 and dhc-1; pct-1 double mutants with the
js319 allele. Similar to the wy622 allele, the js319 allele
completely suppresses the dendritic accumulation of SVPs in
either cdk-5 or pct-1 single mutants (Figures 7B and 7C). The
dhc-1(js319) mutant also strongly suppresses the severe
dendritic RAB-3 defect and reduces the number of retrogradely
moving SVPs in cyy-1 cdk-5 double mutant animals (Figure 7E,
Figure 7J, and Figure 6E). These results suggest the CDK path-
ways promote axonal transport by inhibiting dynein-mediated
retrograde movement in wild-type animals.
NUD-2 Likely Acts Downstream of CDK-5 and PCT-1
To further establish the mechanistic link between the CDK-5
pathways and the cytoplasmic dynein complex, we considered
NUD-2 as a direct target. NUD-2 is the worm ortholog of Nudel,
a component of the cytoplasmic dynein complex that has been
demonstrated as a substrate of CDK5 in vertebrate system (Niet-
hammer et al., 2000; Sasaki et al., 2000). Indeed, we found that
the null nud-2(ok949) allele completely suppresses the dendritic
localization of SVPs in cdk-5 or pct-1 single mutants, and signif-854 Cell 141, 846–858, May 28, 2010 ª2010 Elsevier Inc.icantly suppresses the mislocalization phenotype in the cyy-1
cdk-5 double mutants (Figures 7F–7J). This suppression by
nud-2 is indistinguishable compared with the suppression by
dhc-1. These results indicate that both DHC-1 and NUD-2 func-
tion downstream of the CDK-5/PCT-1 pathways and that CDK-5
and PCT-1 inhibit the activity of the cytoplasmic dynein complex
(Figure 7K).DISCUSSION
Our genetic and imaging experiments provide us with the
followingmodel: The axonal MTs are uniformly orientedwith their
plus-ends toward the axonal tip, while dendrites have mixed
polarity with the preferred orientation being minus-ends toward
the distal dendrite. Two antagonistic forces determine the local-
ization of presynaptic components: the anterogrademotor UNC-
104/KIF1A transporting SVPs toward the axonal tip and the
retrograde motor dynein trafficking SVPs toward the distal
dendrite. PCT-1 and CDK-5 regulate the balance between the
anterograde and retrograde trafficking, most likely by inhibiting
dynein activity. In wild-type animals, PCT-1 andCDK-5 suppress
dynein-mediated transport toward the dendrite, allowing the
UNC-104 motor to dominate and achieve the axonal localization
of presynaptic components. When both CDK pathways are
defective, dynein activity is abnormally high, driving presynaptic
components to dendrites.CYY-1 Activates PCT-1 and Functions in Localizing
Presynaptic Components
Although a large body of evidence implicates cyclins in cell cycle
regulation, there are some exceptions. For example, D-type cy-
clins are upregulated in differentiating hematopoietic cells,
quiescent myotubes, or in fibroblasts undergoing growth arrest,
suggesting their non-mitogenic roles (Furukawa et al., 2000;
Kiess et al., 1995; Meyyappan et al., 1998). Our findings suggest
a post-mitotic role for CYY-1 in regulating intracellular transport
and excluding presynaptic components from the DA9 dendrite.
Like the D-type cyclins, CYY-1 may respond to extracellular
cues by regulating signal transduction. Identifying the extrinsic
signals important for the activity of CYY-1 would provide insight
into the pathway that regulates the localization of presynaptic
components.
Unlike CYY-1, the mammalian homologs of PCT-1 have been
identified and characterized by several groups. Pctaire1, the
best-characterized member of this kinase family, regulates
neurite outgrowth in the Neuro2A neuroblastoma cell line
(Graeser et al., 2002). Pctaire2 is associated with Trap (tudor
repeat associator with Pctaire 2) and ik3-1/cables, the adaptor
that functionally connects c-abl and CDK-5 to support neurite
growth (Yamochi et al., 2001). The third member of this family,
Pctaire3, is implicated in cytoskeletal regulation where it indi-
rectly stimulates the phosphorylation of the MT associated
protein, tau (Herskovits and Davies, 2006). However, the
in vivo functions of these kinases and how they are regulated
are poorly understood. Here we show genetically that cyy-1
falls in the same pathway with pct-1. We further show bio-
chemically that CYY-1 binds to and activates PCT-1. It remains
Figure 7. Loss-of-Function Mutations in Dynein Suppress the Mislocalization Defect in the CDK Mutants
(A) Schematic diagram of DHC-1 protein and mutations. The main domains are N-terminal region 1, N-terminal region 2, a domain conserved among the ATPase
family associated with various cellular activities (AAA), and a C-terminal conserved region.
(B–I) Representative confocal micrographs of GFP::RAB-3 in DA9 (wyIs85) of different genotypes. dhc-1(js319); cdk-5 (B), dhc-1(js319); pct-1 (C), dhc-1(js319)
(D), dhc-1(js319); cyy-1 cdk-5 (E), nud-2; cdk-5 (F), nud-2; pct-1 (G), nud-2 (H) and nud-2; cyy-1 cdk-5 (I). (J) Graph of severity of GFP::RAB-3mislocalization. Error
bars represent SEM n = 20. ***p < 0.0005. t test. (K) Model of the two CDK pathways.to be determined if mammalian cyclin Y activates Pctaire
kinases.
Another upstream activator of Pctaire1 that has been charac-
terized is CDK-5 (Liu et al., 2006). However, the C. elegans
PCT-1 protein lacks the phosphorylation site for CDK-5 and
is unlikely to be its substrate. With regards to downstream
substrates, Pctaire1 has been shown to phosphorylate N-Ethyl-
maleimide-sensitive fusion protein, a factor important for
membrane fusion (Cheng et al., 2002; Liu et al., 2006). Pctaire1
also interacts with p11/calpactin I light chain and 14-3-3, bothof which are associated with multiple factors including
c-kinase, Raf, Bcr, and PI3-kinase, but none of them have
been identified as a substrate of Pctaire kinases (Le Bouffant
et al., 1998). Due to the limited information available about
the substrates of Pctaire kinases, it is hard to deduce
a consensus substrate motif. However, similar to other CDKs
or CDK-5, they likely phosphorylate the sequence (S/T)PX(K/
H/R) (Liu et al., 2006). Further understanding of other features
common to substrates of Pctaire kinases is needed to elucidate
the mechanism of its function.Cell 141, 846–858, May 28, 2010 ª2010 Elsevier Inc. 855
CDKs and Axonal Transport
In contrast to Pctaire kinases and cyclin Y, the proline-directed
serine threonine kinase CDK-5 has been studied extensively
and has been implicated in many aspects of neuronal develop-
ment, such as neuronal migration, neurite outgrowth, synaptic
formation, and neuronal survival (Gilmore et al., 1998; Kwon
and Tsai, 1998; Ohshima et al., 1996; Yip et al., 2007). Astonish-
ingly large numbers of putative CDK-5 substrates have been
identified and these substrates are associated with cytoskeletal
structures including MTs, as well as membrane dynamics and
synaptic assembly (Cheung et al., 2006; Samuels et al., 2007;
Smith, 2003; Xie et al., 2006). Among these, what might mediate
the effect of CDK-5 or its related kinase PCT-1 on axonal traf-
ficking?
Proper localization of presynaptic components involves
multiple steps, including MT-based transport over long
distances and local assembly at presynaptic specializations.
As CDK-5 phosphorylates multiple MT-associated proteins
and Pctaire3 indirectly phosphorylates tau (Herskovits and
Davies, 2006), the CDKs may regulate the localization of presyn-
aptic components by reorganizing the cytoskeleton. We did not
detect major alterations to MT polarity and general axon
morphology when both CDK pathways are disrupted, suggest-
ing that cytoskeletal rearrangement is unlikely to be the major
or only cause of mislocalized presynaptic components.
However, our assay for MT polarity might not be sensitive
enough to detect subtle changes of polarity.
CDK-5 was recently shown to recruit the MAGUK family
member CASK, an active zone protein that interacts with calcium
channels and multiple adaptor proteins, to presynaptic sites
(Samuels et al., 2007). In C. elegans, the phenotype of a strong
assembly defect in DA9 is distinct from the defect in mutants
in the two CDK pathways (Figure S5S-T). Therefore, while
CDK-5 might also affect the local assembly of presynaptic
specializations in DA9, it is unlikely that the CDKs maintain
proper localization of presynaptic components solely through
regulating synapse assembly.
Our genetic and cell biology experiments suggest that the
CDK pathways affect intracellular trafficking by regulating motor
proteins. Several studies support the involvement of CDK-5 or its
related kinase in axonal transport. First, in the squid giant axon,
the CDK inhibitor olomoucin affects fast anterograde movement
while substrates for proline-directed kinases like KSPXK peptide
and histone H1 decrease both anterograde and retrograde
transport (Ratner et al., 1998). Second, adding the CDK inhibitor
olomoucin or knocking out CDK-5 activators p35 or p39
increases kinesin light chain phosphorylation, which may cause
cargo release and the slowing down of fast anterograde axonal
transport of membrane-bound organelles (Morfini et al., 2004;
Morfini et al., 2002). Third andmost relevant to this study, a series
of elegant biochemistry studies showed that CDK-5 phosphory-
lates Nudel, a factor that associates with the retrograde motor
dynein and its regulator LIS1 and this phosphorylation event
regulates neuronal migration and neurite morphology
(Niethammer et al., 2000; Sasaki et al., 2000). Taken together,
CDK-5 and its related kinases regulate the balance of antero-
grade and retrograde motors. Since the defect of SVP localiza-
tion can be restored largely by the dhc-1 and nud-2 mutations856 Cell 141, 846–858, May 28, 2010 ª2010 Elsevier Inc.(Figure 7), we propose that CDK-5 and PCT-1 mainly repress
retrograde transport to localize presynaptic components to
axons and this may occur through the dynein complex.Interactions between PCT-1/CYY-1 and CDK-5/p35
Our genetic double mutant analysis showed that PCT-1 and
CYY-1 function in the same genetic pathway, while CDK-5 and
CDKA-1/p35 act together. This notion is supported by the fact
that CYY-1 binds directly to PCT-1 and is required for the kinase
activity of PCT-1 in vitro. However, CYY-1 might also stimulate
the activity of the CDK-5 pathway as a CYY-1 transgene can
rescue the pct-1 mutant but not pct-1 cdk-5 double mutants.
CDK-5 and its activators p35 and p39 are evolutionarily
conserved across eukaryotic species and no cyclin-like activa-
tors of CDK-5 have been characterized. It is intriguing that our
genetic studies suggest that the CYY-1 can act upstream of
CDK-5 and its activator CDKA-1/p35. Moreover, although
canonical cyclins cannot affect CDK-5 activity, they can still
bind CDK-5 (Miyajima et al., 1995; Yip et al., 2007). Consistent
with our genetic analysis, we found that CYY-1 can efficiently
stimulate CDK-5 kinase activity in vitro. How CYY-1 regulates
PCT-1 and CDK-5 to target presynaptic components in
a spatially specific manner is worth investigating, especially
since other cyclins generally behave as temporal regulators.EXPERIMENTAL PROCEDURES
Strains and Genetics
Worms were raised on OP50 E. coli seeded NGM plates at 22C. The following
mutant strains were obtained through the Caenorhabditis Genetics Center:
RB814 cdk-5(ok626)III, CB1265 unc-104(e1265)II, RB1471 pct-1(ok1707)IV,
WM99 cdk-1(ne2257)II, JH1288 cdk-7(ax224I), CZ1893 syd-1(ju82)II, and
RB1022 nud-2(ok949)I. FX00648 cdka-1(tm648)III, FX02175 pct-1(tm2175)IV,
and FX01238 cdk-8(tm1238)I were kindly provided by Shohei Mitani.
NM1489 dhc-1(js319); jsIs37 was kindly provided by Mike Nonet. TV74
syd-2(wy5)X, a null allele(Chao, unpublished), and TV6851 unc-
104(e1265wy565), a weak allele (K.S., unpublished data) was previously iso-
lated from our lab. N2 Bristol was utilized as the wild-type reference strain.
Genetic Screens
wy575 was isolated from an F2 semiclonal visual screen of 600 haploid
genomes for lin-44/wnt(n1792); wyIs85 enhancers. wy302 was isolated from
an F2 semiclonal visual screen of 3000 haploid genomes from the wyIs109
strain.wy622was isolated from an F2 semiclonal visual screen of 3000 haploid
genomes for cdk-5(ok626); wyIs85 enhancers. wy565 was isolated from an F2
behavioral screen of 1200 haploid genomes for unc-104(e1265); wyIs87
suppressors. Worms were mutagenized with 50 mM EMS.
Cloning and Constructs
Expression clones were made in a derivative of pPD49.26 (A. Fire, personal
communication), the pSM vector (S. McCarroll and C. I. Bargmann, personal
communication). The plasmids and strains were generated as previously
described (Klassen and Shen, 2007; Margeta et al., 2009). We utilized the co-
injection markers Podr-1::GFP or dsRED injected at 20ng ml-1 and transgenes
were introduced intoC. elegans as previously described (Mello and Fire, 1995).
Fluorescence Microscopy and Confocal Imaging
Images of fluorescently-tagged fusion proteins were captured in live
C. elegans using a Plan-Apochromat 63X/1.4 objective on a Zeiss LSM510
or LSM710 confocal microscope. Worms were immobilized using 1.25mM
levamisole (Sigma) and 112.5mM 2,3-butanedione monoxime (Sigma).
Electron Microscopy
N2 and cyy-1 cdk-5 animals were processed for electron microscopy essen-
tially as previously described (Hammarlund et al., 2007) and supplement
methods. A total of 12mm segments were reconstructed for each strain
and annotated using ImageJ. The DA, DB, and DD neurons were recognized
by their orientation pattern (White et al., 1986). A varicosity was defined as
a series of profiles with an area larger than 10,000 square nm. In N2 animals,
seven DA, six DB, and five DD varicosities were analyzed. In cyy-1 cdk-5
double mutants, eight DA, four DB, and six DD varicosities were analyzed.
Dynamic Imaging
Dynamic imaging was performed on the inverted Zeiss Axio Observer Z1
microscope equipped with the highly sensitive QuantEM:512SC camera. A
Plan-Apochromat 63X/1.4 objective was used for acquisition.
L4 worms were cultured at 25C for imaging. They were mounted onto 2%
agarose pads and anesthetized with 6mM levamisol (Sigma) for no longer than
20min.
All movies were acquired over 40 s with 7 frames per second and an illumi-
nation time of 100ms. Movies were then analyzed using the ImageJ software.
Coimmunoprecipitation and Kinase Activity Assays
Mammalian expression constructs encoding C. elegans CYY-1-FLAG and
PCT-1-HA were overexpressed in HEK293T cells by lipofectamine plus (Invi-
trogen) and coimmunoprecipated by anti-FLAG (Sigma) or anti-HA (Roche)
antibodies (2 mg) as previously described (Fu et al., 2007).
For in vitro kinase assays, mammalian expression constructs encoding
C. elegans CYY-1-FLAG with PCT-1-HA or CDK-5-HA were overexpressed
in HEK293T cells as previously described (Cheng et al., 2002). The PCT-1 or
CDK-5 complex was coimmunoprecipitated using anti-HA antibody (Santa
Cruz). Recombinant myelin basic protein (0.5 mg; Calbiochem) or recombinant
Histone H1 protein (5 mg; Calbiochem) was used as a substrate for PCT-1 or
CDK-5 respectively in the in vitro kinase assays.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
six figures and can be found with this article online at doi:10.1016/j.cell.
2010.04.011.
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